On Air Now

Listen

Listen Live Now » 101.1 FM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
66° Feels Like: 66°
Wind: S 0 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Mostly Sunny 77°

Tonight

Partly Cloudy 58°

Tomorrow

PM Thunderstorms 78°

Alerts

Alnylam's drug reduces bad cholesterol in early study

(Reuters) - Alnylam Pharmaceuticals Inc said an early-stage trial of its experimental cholesterol treatment showed the therapy reduced up to half the level of bad cholesterol in patients.

The main goal of the study was to test the safety and tolerability of a single dose of the treatment, ALN-PCS -- which works by targeting a specific gene that is associated with high levels of bad cholesterol.

ALN-PCS showed a statistically significant gene-silencing rate of 66 percent.

The drug was found to be safe and well tolerated, and there were no serious adverse events related to it, the company said in a statement.

Given the favorable safety profile and efficacy achieved, the company plans to continue the study with higher doses.

Additional results from the study are expected in the first half of this year.

Shares of the Cambridge, Massachusetts-based company closed at $8.66 on Tuesday on Nasdaq.

(Reporting by Balaji Sridharan in Bangalore; Editing by Roshni Menon)

Comments